De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
03 2020
Historique:
received: 16 07 2019
accepted: 23 10 2019
revised: 22 10 2019
pubmed: 15 11 2019
medline: 4 2 2021
entrez: 15 11 2019
Statut: ppublish

Résumé

Intellectual disability (ID) and autism spectrum disorder (ASD) are genetically heterogeneous neurodevelopmental disorders. We sought to delineate the clinical, molecular, and neuroimaging spectrum of a novel neurodevelopmental disorder caused by variants in the zinc finger protein 292 gene (ZNF292). We ascertained a cohort of 28 families with ID due to putatively pathogenic ZNF292 variants that were identified via targeted and exome sequencing. Available data were analyzed to characterize the canonical phenotype and examine genotype-phenotype relationships. Probands presented with ID as well as a spectrum of neurodevelopmental features including ASD, among others. All ZNF292 variants were de novo, except in one family with dominant inheritance. ZNF292 encodes a highly conserved zinc finger protein that acts as a transcription factor and is highly expressed in the developing human brain supporting its critical role in neurodevelopment. De novo and dominantly inherited variants in ZNF292 are associated with a range of neurodevelopmental features including ID and ASD. The clinical spectrum is broad, and most individuals present with mild to moderate ID with or without other syndromic features. Our results suggest that variants in ZNF292 are likely a recurrent cause of a neurodevelopmental disorder manifesting as ID with or without ASD.

Identifiants

pubmed: 31723249
doi: 10.1038/s41436-019-0693-9
pii: S1098-3600(21)01257-0
pmc: PMC7060121
mid: NIHMS1543809
doi:

Substances chimiques

Carrier Proteins 0
Nerve Tissue Proteins 0
ZNF292 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

538-546

Subventions

Organisme : NHLBI NIH HHS
ID : UM1 HL098162
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007690
Pays : United States
Organisme : CIHR
ID : MOP-102758
Pays : Canada
Organisme : NHLBI NIH HHS
ID : UM1 HL098123
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS092772
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007674
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007672
Pays : United States
Organisme : NINDS NIH HHS
ID : K08 NS092898
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001085
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006493
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL128711
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL098147
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007942
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003142
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL131003
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007708
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG010218
Pays : United States
Organisme : NCATS NIH HHS
ID : U01 TR001395
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007709
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL128761
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007943
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS093793
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007530
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG008956
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007703
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101221
Pays : United States

Références

Chong JX, Yu JH, Lorentzen P, et al. Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features. Genet Med. 2016;18:788–795.
doi: 10.1038/gim.2015.161
de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921–1929.
doi: 10.1056/NEJMoa1206524
Kochinke K, Zweier C, Nijhof B, et al. Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules. Am J Hum Genet. 2016;98:149–164.
doi: 10.1016/j.ajhg.2015.11.024
O’Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585–589.
doi: 10.1038/ng.835
Lipkin SM, Naar AM, Kalla KA, Sack RA, Rosenfeld MG. Identification of a novel zinc finger protein binding a conserved element critical for Pit-1-dependent growth hormone gene expression. Genes Dev. 1993;7:1674–1687.
doi: 10.1101/gad.7.9.1674
Takeda H, Wei Z, Koso H, et al. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression. Nat Genet. 2015;47:142–150.
doi: 10.1038/ng.3175
Philippakis AA, Azzariti DR, Beltran S, et al. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum Mutat. 2015;36:915–921.
doi: 10.1002/humu.22858
Guo H, Wang T, Wu H, et al. Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Mol Autism. 2018;9:64.
doi: 10.1186/s13229-018-0247-z
Popp B, Ekici AB, Thiel CT, et al. Exome Pool-Seq in neurodevelopmental disorders. Eur J Hum Genet. 2017;25:1364–1376.
doi: 10.1038/s41431-017-0022-1
Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886–D894.
doi: 10.1093/nar/gky1016
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–423.
doi: 10.1038/gim.2015.30
Camacho N, Van Loo P, Edwards S, et al. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. PLoS Genet. 2017;13:e1007001.
doi: 10.1371/journal.pgen.1007001
Lee JH, Song SY, Kim MS, Yoo NJ, Lee SH. Frameshift mutations of a tumor suppressor gene ZNF292 in gastric and colorectal cancers with high microsatellite instability. APMIS. 2016;124:556–560.
doi: 10.1111/apm.12545
Yang P, Qiu Z, Jiang Y, et al. Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/beta-catenin signaling pathway. Oncotarget. 2016;7:63449–63455.
pubmed: 27613831 pmcid: 5325376
Kosugi S, Hasebe M, Tomita M, Yanagawa H. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci U S A. 2009;106:10171–10176.
doi: 10.1073/pnas.0900604106
Wolf E, Kim PS, Berger B. MultiCoil: a program for predicting two- and three-stranded coiled coils. Protein Sci. 1997;6:1179–1189.
doi: 10.1002/pro.5560060606
Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291.
doi: 10.1038/nature19057
Akle S, Chun S, Jordan DM, Cassa CA. Mitigating false-positive associations in rare disease gene discovery. Hum Mutat. 2015;36:998–1003.
doi: 10.1002/humu.22847
Ware JS, Samocha KE, Homsy J, Daly MJ. Interpreting de novo variation in human disease using denovolyzeR. Curr Protoc Hum Genet. 2015;87:7.25.
Coban-Akdemir Z, White JJ, Song X, et al. Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles. Am J Hum Genet. 2018;103:171–187.
doi: 10.1016/j.ajhg.2018.06.009
De Rubeis S, He X, Goldberg AP, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515:209–215.
doi: 10.1038/nature13772
Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433–438.
doi: 10.1038/nature21062
Homsy J, Zaidi S, Shen Y, et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science. 2015;350:1262–1266.
doi: 10.1126/science.aac9396
Wang T, Guo H, Xiong B, et al. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun. 2016;7:13316.
doi: 10.1038/ncomms13316
Hsu MK, Lin HY, Chen FC. NMD Classifier: a reliable and systematic classification tool for nonsense-mediated decay events. PLoS One. 2017;12:e0174798.
doi: 10.1371/journal.pone.0174798
Engwerda A, Frentz B, den Ouden AL, et al. The phenotypic spectrum of proximal 6q deletions based on a large cohort derived from social media and literature reports. Eur J Hum Genet. 2018;26:1478–1489.
doi: 10.1038/s41431-018-0172-9

Auteurs

Ghayda M Mirzaa (GM)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA. ghayda.mirzaa@seattlechildrens.org.
Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. ghayda.mirzaa@seattlechildrens.org.
Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA. ghayda.mirzaa@seattlechildrens.org.

Jessica X Chong (JX)

Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.

Amélie Piton (A)

Molecular Genetic Unit, Strasbourg University Hospital, Strasbourg, France.
Institute of Genetics and Molecular and Cellular Biology, Université de Strasbourg, Illkirch, France.

Bernt Popp (B)

Institute of Human Genetics, University Hospital Elrangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

Kimberly Foss (K)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Hui Guo (H)

Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.

Ricardo Harripaul (R)

The Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Kun Xia (K)

Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.

Joshua Scheck (J)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Kimberly A Aldinger (KA)

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.

Samin A Sajan (SA)

Department of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.

Sha Tang (S)

WuXi NextCODE, Cambridge, MA, USA.

Dominique Bonneau (D)

Département de Biochimie et de Génétique, CHU d'Angers, Angers, France.
UMR INSERM 1083 CNRS 6015, Angers, France.

Anita Beck (A)

Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

Janson White (J)

Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.

Sonal Mahida (S)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.

Jacqueline Harris (J)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.

Constance Smith-Hicks (C)

Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.

Juliane Hoyer (J)

Institute of Human Genetics, University Hospital Elrangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

Christiane Zweier (C)

Institute of Human Genetics, University Hospital Elrangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

André Reis (A)

Institute of Human Genetics, University Hospital Elrangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

Christian T Thiel (CT)

Institute of Human Genetics, University Hospital Elrangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.

Rami Abou Jamra (RA)

Institute of Human Genetics, University Medical Center Leipzig, Leipzig, Germany.

Natasha Zeid (N)

Yale New Haven Health, New Haven, CT, USA.

Amy Yang (A)

Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.

Laura S Farach (LS)

Department of Pediatrics, McGovern Medical School at the University of Texas Health Sciences Center, Houston, TX, USA.

Laurence Walsh (L)

Indiana University Health at Riley Hospital for Children, Indianapolis, IN, USA.

Katelyn Payne (K)

Indiana University Health at Riley Hospital for Children, Indianapolis, IN, USA.

Luis Rohena (L)

Division of Genetics, Department of Pediatrics, San Antonio Military Medical Center, San Antonio, TX, USA.
Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Milen Velinov (M)

New York State Institute for Basic Research in Developmental Disability, NY, Staten Island, USA.

Alban Ziegler (A)

Département de Biochimie et de Génétique, CHU d'Angers, Angers, France.
Service de Génétique Médicale, Centre hospitalier, Le Mans, France.

Elise Schaefer (E)

Service de Génétique Médicale, Hôpitaux Universitaires de Strasbourg, Institut de Génétique Médicale d'Alsace, Strasbourg, France.

Vincent Gatinois (V)

Service de génétique clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Strasbourg, France.
Centre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Sud-Ouest Occitanie Réunion, Hôpital Arnaud de Villeneuve, Montpellier, France.
Université Montpellier, Unité Inserm U1183, Montpellier, France.

David Geneviève (D)

Service de génétique clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Strasbourg, France.
Centre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Sud-Ouest Occitanie Réunion, Hôpital Arnaud de Villeneuve, Montpellier, France.
Université Montpellier, Unité Inserm U1183, Montpellier, France.

Marleen E H Simon (MEH)

Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Jennefer Kohler (J)

Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, CA, USA.

Joshua Rotenberg (J)

Memorial Hermann Memorial City Medical Center, Houston, TX, USA.

Patricia Wheeler (P)

Arnold Palmer Hospital for Children, Orlando, FL, USA.

Austin Larson (A)

Section of Genetics, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.

Michelle E Ernst (ME)

Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Cigdem I Akman (CI)

Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Division of Pediatric Neurology, Columbia University Irving Medical Center, New York, NY, USA.

Rachel Westman (R)

Division of Genetics, St. Luke's Clinic, Boise, ID, USA.

Patricia Blanchet (P)

Centre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Sud-Ouest Occitanie Réunion, Hôpital Arnaud de Villeneuve, Montpellier, France.

Lori-Anne Schillaci (LA)

Department of Genetics and Genome Sciences, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Catherine Vincent-Delorme (C)

Service de Génétique Clinique Guy Fontaine Centre de référence maladies rares Anomalies du dévelopement, Hôpital Jeanne de Flandre Lille, Lille, France.

Karen W Gripp (KW)

Department of Pediatrics, AI duPont Hospital, DE, Wilmington, USA.

Francesca Mattioli (F)

Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch-Graffenstaden, Lille, France.

Gwenaël Le Guyader (GL)

Service de Génétique Clinique, Centre de compétence Maladies rares Anomalies du dévelopement, CHU de Poitiers, Poitiers, France.

Bénédicte Gerard (B)

Molecular Genetic Unit, Strasbourg University Hospital, Strasbourg, France.

Michèle Mathieu-Dramard (M)

Service de Génétique Clinique Centre de référence maladies rares Anomalies du dévelopement, CHU Amiens-Picardie, Amiens, France.

Gilles Morin (G)

Children's Medical Center, UMass Memorial Medical Center, Worcester, MA, USA.

Roksana Sasanfar (R)

Children's Medical Center, UMass Memorial Medical Center, Worcester, MA, USA.

Muhammad Ayub (M)

Department of Psychiatry, Queen's University, Kingston, ON, Canada.

Nasim Vasli (N)

Division of Clinical & Metabolic Genetics, Hospital for Sick Children, Toronto, ON, Canada.

Sandra Yang (S)

GeneDx, Gaithersburg, MD, USA.

Rick Person (R)

GeneDx, Gaithersburg, MD, USA.

Kristin G Monaghan (KG)

GeneDx, Gaithersburg, MD, USA.

Deborah A Nickerson (DA)

Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.

Ellen van Binsbergen (E)

Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Gregory M Enns (GM)

Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, CA, USA.
Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Stanford, CA, USA.

Annika M Dries (AM)

Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, CA, USA.

Leah J Rowe (LJ)

Section of Genetics, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.

Anne C H Tsai (ACH)

Section of Genetics, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.

Shayna Svihovec (S)

Section of Genetics, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.

Jennifer Friedman (J)

Departments of Neurosciences and Pediatrics, University of California San Diego and Division of Neurology, Rady Children's Hospital, San Diego, CA, USA.
Rady Children's Institute for Genomic Medicine, San Diego, CA, USA.

Zehra Agha (Z)

Department of Biosciences, COMSATS University, Islamabad, Pakistan.

Raheel Qamar (R)

Department of Biosciences, COMSATS University, Islamabad, Pakistan.

Lance H Rodan (LH)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Julian Martinez-Agosto (J)

David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Charlotte W Ockeloen (CW)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Marie Vincent (M)

CHU de Nantes, Service de génétique médicale, Nantes, France.

William James Sunderland (WJ)

University of Washington Foundation Board, University of Washington, Seattle, WA, USA.

Jonathan A Bernstein (JA)

Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, CA, USA.
Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Stanford, CA, USA.

Evan E Eichler (EE)

Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.

John B Vincent (JB)

The Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health (CAMH), Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Michael J Bamshad (MJ)

Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH